Publication details

Erlotinib u nemocných s nemalobuněčným karcinomem plic (NSCLC) : sledování účinnosti u nemocných v České republice

Title in English Erlotinib in patients with non-small cell lung cancer (NSCLC): Followup of efficacy in patients in the Czech Republic
Authors

SALAJKA František SKŘIČKOVÁ Jana PEŠEK M. ZATLOUKAL P.

Year of publication 2010
Type Article in Proceedings
Conference Sborník XXXIV. Brněnské onkologické dny
MU Faculty or unit

Faculty of Medicine

Citation
Field Pneumology
Keywords Erlotinib; NSCLS; Czech Republic
Description Efficacy of Erlotinib in treatment of non-small cell lung cancer (NSCLC) was followed up in this Czech multi-centre study.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.

More info